WO2001079974A3 - Haplotypes du gene f9 - Google Patents

Haplotypes du gene f9 Download PDF

Info

Publication number
WO2001079974A3
WO2001079974A3 PCT/US2001/012012 US0112012W WO0179974A3 WO 2001079974 A3 WO2001079974 A3 WO 2001079974A3 US 0112012 W US0112012 W US 0112012W WO 0179974 A3 WO0179974 A3 WO 0179974A3
Authority
WO
WIPO (PCT)
Prior art keywords
gene
haplotypes
disclosed
polymorphisms
haplotyping
Prior art date
Application number
PCT/US2001/012012
Other languages
English (en)
Other versions
WO2001079974A2 (fr
Inventor
Anne Chew
Julie Y Choi
Beena Koshy
Original Assignee
Genaissance Pharmaceuticals
Anne Chew
Julie Y Choi
Beena Koshy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genaissance Pharmaceuticals, Anne Chew, Julie Y Choi, Beena Koshy filed Critical Genaissance Pharmaceuticals
Priority to AU2001253431A priority Critical patent/AU2001253431A1/en
Publication of WO2001079974A2 publication Critical patent/WO2001079974A2/fr
Publication of WO2001079974A3 publication Critical patent/WO2001079974A3/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne des nouveaux polymorphismes de nucléotide simple dans le gène du facteur IX de coagulation humain (F9). De plus, l'invention concerne plusieurs génotypes, haplotypes et paires d'haplotypes destinés au gène F9 existant dans la population. L'invention concerne également des compositions et des procédés permettant d'haplotyper et/ou de génotyper le gène F9 chez un individu. L'invention concerne en outre des polynucléotides renfermant un ou plusieurs polymorphismes F9 décrits ci-dessus.
PCT/US2001/012012 2000-04-12 2001-04-11 Haplotypes du gene f9 WO2001079974A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001253431A AU2001253431A1 (en) 2000-04-12 2001-04-11 Haplotypes of the f9 gene

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19641900P 2000-04-12 2000-04-12
US60/196,419 2000-04-12

Publications (2)

Publication Number Publication Date
WO2001079974A2 WO2001079974A2 (fr) 2001-10-25
WO2001079974A3 true WO2001079974A3 (fr) 2002-03-21

Family

ID=22725336

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/012012 WO2001079974A2 (fr) 2000-04-12 2001-04-11 Haplotypes du gene f9

Country Status (2)

Country Link
AU (1) AU2001253431A1 (fr)
WO (1) WO2001079974A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104046699B (zh) * 2014-07-08 2016-03-02 上海交通大学医学院附属瑞金医院 F9基因拷贝数变异检测试剂盒

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE GENBANK [online] 23 November 1999 (1999-11-23), XP002906035, Database accession no. AL033403 *
DATABASE SNP [online] NATIONAL CENTER FOR BIOTECHNOLOGY INFORMATION, NATIONAL LIBRARY OF MEDICINE, NIH (BETHESDA, MD, USA); January 2001 (2001-01-01), XP002906034, retrieved from ss7662 accession no. NCBI Database accession no. rs6048 *
YOSHITAKE S. ET AL.: "Nucleotide sequence of the gene for human factor IX", BIOCHEMISTRY, vol. 24, 1985, pages 3736 - 3750, XP002906033 *

Also Published As

Publication number Publication date
WO2001079974A2 (fr) 2001-10-25
AU2001253431A1 (en) 2001-10-30

Similar Documents

Publication Publication Date Title
WO2001079234A3 (fr) Haplotypes du gene apoe
WO2001079229A3 (fr) Haplotypes du gene cxcr4
WO2001090123A3 (fr) Haplotypes du gene agtrl1
WO2001079230A3 (fr) Haplotypes du gene ugt1a1
WO2001079228A3 (fr) Haplotypes du gene f12
WO2001077124A3 (fr) Haplotypes du gene apoa4
WO2001079974A3 (fr) Haplotypes du gene f9
WO2001077363A3 (fr) Haplotypes du gene impdh2
WO2001079224A3 (fr) Haplotypes du gene cyp8b1
WO2002018414A3 (fr) Haplotypes du gène bf
WO2001077131A3 (fr) Haplotypes du gene bglap
WO2001079240A3 (fr) Haplotypes du gene rangap1
WO2001079218A3 (fr) Haplotypes du gene calm1
WO2001079219A3 (fr) Haplotypes du gene ache
WO2001077129A3 (fr) Haplotypes du gene apoc1
WO2001079232A3 (fr) Haplotypes du gene mpl
WO2001072965A3 (fr) Haplotypes du gene fkbp8
WO2001072966A3 (fr) Haplotypes du gene pltp
WO2001079223A3 (fr) Haplotypes du gene akr1b1
WO2001090127A3 (fr) Haplotypes du gene de hoxd3
WO2001077127A3 (fr) Haplotypes du gene apoc4
WO2001077132A3 (fr) Haplotypes du gene il5
WO2001079237A3 (fr) Haplotypes du gene galr1
WO2001075065A3 (fr) Haplotypes du gene gp1ba
WO2001077130A3 (fr) Haplotypes du gene apoa2

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP